Livzon Pharmaceutical Group Inc (LVZPF PINK) stock market data APIs

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric-coated tablets and ilaprazole sodium for injection a series of bismuth potassium citrate products for gastrointestinal field; leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for assisted reproduction field; fluvoxamine maleate and perospirone hydrochloride tablets for psychiatric and neurological field; and shenqi fuzheng injection and anti-viral granules for traditional chinese medicine field. It also produces APIs and intermediates, such as mevastatin, acarbose, phenylalanine, vancomycin hydrochloride, daptomycin, milbemycin oxime, and ceftriaxone sodium; diagnostic reagents such as diagnostic kit for IgM antibody to mycoplasma pneumonia; diagnostic kit for human immunodeficiency virus antibody; and livzon antinuclear antibody test kit. In addition, the company offers nucleic acid test kits; livzon interferon-gamma release assays test kits; diagnostic kit for IgM antibody to mycoplasma pneumonia; influenza A/B virus antigen detection kit; and treponema pallidum antibody detection kit. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics, as well as diagnostic reagents and equipment. Livzon Pharmaceutical Group Inc. was founded in 1985 and is headquartered in Zhuhai, China.